Rigel Pharmaceuticals (RIGL) Net Equity Issued and Repurchased (2010 - 2018)
Rigel Pharmaceuticals (RIGL) posted quarterly Net Equity Issued and Repurchased of $8.8 million for Q2 2018, up 183.38% year-over-year from $3.1 million in Q2 2017, and up 53.72% quarter-over-quarter from $5.7 million in Q4 2017.
Rigel Pharmaceuticals (RIGL) Net Equity Issued and Repurchased (2010 - 2018) Analysis & Trends
Rigel Pharmaceuticals' Net Equity Issued and Repurchased history runs 9 years deep, the most recent figure standing at $8.8 million for Q2 2018.
- In Q2 2018, Net Equity Issued and Repurchased rose 183.38% year-over-year to $8.8 million; the TTM figure through Dec 2018 stood at $14.5 million (down 73.44% YoY), while the FY2018 annual figure was $67.2 million, down 41.18% from the prior year.
- Net Equity Issued and Repurchased for Q2 2018 stood at $8.8 million, up from $5.7 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $43.1 million in Q1 2017, with the low at $5000.0 in Q3 2014.
- The 5-year median for Net Equity Issued and Repurchased is $2.6 million (2017), against an average of $6.5 million.
- The sharpest annual moves came in 2016 and 2017: Net Equity Issued and Repurchased jumped 32252.94% in 2016, then plunged 91.44% in 2017.
- Rigel Pharmaceuticals' Net Equity Issued and Repurchased stood at $480000.0 in 2014, then jumped by 767.71% to $4.2 million in 2015, then plunged by 68.79% to $1.3 million in 2016, then soared by 338.46% to $5.7 million in 2017, then jumped by 53.72% to $8.8 million in 2018.
- Business Quant data shows RIGL's Net Equity Issued and Repurchased at $8.8 million in Q2 2018, $5.7 million in Q4 2017, and $2.6 million in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 38,000.00 |
| Dec 31, 2018 | 38,000.00 |
| Jun 30, 2018 | 8.76 Mn |
| Jun 30, 2018 | 8.76 Mn |
| Dec 31, 2017 | 5.70 Mn |
| Dec 31, 2017 | 5.70 Mn |
| Sep 30, 2017 | 2.57 Mn |
| Sep 30, 2017 | 2.57 Mn |
| Jun 30, 2017 | 3.09 Mn |
| Jun 30, 2017 | 3.09 Mn |
| Mar 31, 2017 | 43.08 Mn |
| Mar 31, 2017 | 43.08 Mn |
| Dec 31, 2016 | 1.30 Mn |
| Dec 31, 2016 | 1.30 Mn |
| Sep 30, 2016 | 30.00 Mn |
| Sep 30, 2016 | 30.00 Mn |
| Jun 30, 2016 | 3.85 Mn |
| Jun 30, 2016 | 3.85 Mn |
| Mar 31, 2016 | 5.50 Mn |
| Mar 31, 2016 | 5.50 Mn |